Clinical Trial Update: SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury

View source ↗

Summary

SMOF Lipid has received marketing approval for use in pediatric patients with parenteral nutrition–induced liver injury, associated with cholestasis and growth …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis
• Growth Failure

Drugs mentioned

• SMOF Lipid (lipid emulsion (SMOFlipid))

Snippet

Sponsor: Baylor College of Medicine | Conditions: Cholestasis, Growth Failure | Status: APPROVED_FOR_MARKETING